![]() Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | ![]() Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. | |||
Founding Date | Founding Date 2001 | Founding Date 1998 | Founding Date 2007 | Founding Date 2020 |
Type | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Gent, BE HQ | Locations Boston, US HQ Jerusalem, IL | Locations Tres Cantos, ES HQ | Locations Rockville, US HQ Cambridge, US |
Employees | Employees 1252% decrease | Employees 143175% increase | Employees 28 | Employees 502% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income (€1.1m) (FY, 2016) | Net income ($63m) (FY, 2023) | Net income N/A | Net income N/A |
Operating ⚠ | ||||
Patients Reached | Patients Reached 2 k (Q2, 2017) | Patients Reached 120 (Q3, 2018) | Patients Reached N/A | Patients Reached N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 9.4m (about 14 years ago) | Latest funding round $ 150m (over 2 years ago) |
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 128.3m | Total funding raised $ 9.4m | Total funding raised $ 150m |

Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
View company
Vivia Biotech is a company specializing in providing individualized medicine.
View company
Clasp Therapeutics is a company that provides immuno-oncology solutions.
View company